Hemab Therapeutics Holdings, Inc. COAG
38.66 USD -0.49 (-1.25%)
As ofNov 19, 2026, 11:31 AM EST
37.91 Day range 39.58
23.00 52-week range 55.42
- YTD
- +13.71%
- 1 year
- +13.71%
Next earnings
Feb 9, 2027
Expected Feb 9, 2027. Consensus EPS estimate -0.54912.
Included in Essentials and up
Sign in to see Estimates and results by quarter
Analyst estimates for the coming quarters next to what the company reported.
Earnings history
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 9, 2027 | Dec 30, 2026 | -0.59 | — | — | — |
| Nov 10, 2026 | Sep 30, 2026 | -0.50194 | -0.58 | -0.08 | -15.55% |
| Aug 11, 2026 | Jun 30, 2026 | -0.7325 | -0.80 | -0.07 | -9.22% |
| May 21, 2026 | Mar 31, 2026 | -23.25 | -23.98 | -0.73 | -3.16% |
